Literature DB >> 26467063

Metabolic Alterations in Renal and Prostate Cancer.

Chiara Ciccarese, Matteo Santoni, Francesco Massari, Alessandra Modena, Francesco Piva, Alessandro Conti, Roberta Mazzucchelli, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Giampaolo Tortora, Rodolfo Montironi1.   

Abstract

BACKGROUND: Cancer metabolism is emerging as a promising research area in genitourinary tumors. Both renal cell carcinoma (RCC) and prostate cancer (PCa) cells exhibit marked alterations of their metabolism. These changes include increased aerobic glycolysis (the Warburg effect), increased protein and DNA synthesis and de novo fatty acid (FA) synthesis.
OBJECTIVE: Understanding the molecular mechanisms underlying such alterations will represent a major step forward in cancer research. Indeed, reprogramming cancer cell energy metabolism represents a promising hallmark of cancer and may pave the way for novel personalized approaches.
METHOD: PubMed databases were searched for articles published about cancer metabolism in genitourinary tumors. RESULTS AND
CONCLUSION: This review is focused on the metabolic alterations that occur in RCC and PCa and describes the mechanisms underlying such metabolic changes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26467063     DOI: 10.2174/1389200216666151015112356

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  7 in total

1.  Key players of neuroendocrine differentiation in prostate cancer.

Authors:  Matteo Santoni; Gaetano Aurilio; Alessandro Maccioni; Franco Nolè; Nicola Battelli
Journal:  Ann Transl Med       Date:  2019-07

2.  Heterogeneous Expression and Subcellular Localization of Pyruvate Dehydrogenase Complex in Prostate Cancer.

Authors:  Caroline E Nunes-Xavier; Janire Mingo; Maite Emaldi; Karine Flem-Karlsen; Gunhild M Mælandsmo; Øystein Fodstad; Roberto Llarena; José I López; Rafael Pulido
Journal:  Front Oncol       Date:  2022-05-25       Impact factor: 5.738

3.  A urologist's perspective on prostate cancer imaging: past, present, and future.

Authors:  Arvin K George; Baris Turkbey; Subin G Valayil; Akhil Muthigi; Francesca Mertan; Michael Kongnyuy; Peter A Pinto
Journal:  Abdom Radiol (NY)       Date:  2016-05

4.  Aberrant FGFR Tyrosine Kinase Signaling Enhances the Warburg Effect by Reprogramming LDH Isoform Expression and Activity in Prostate Cancer.

Authors:  Junchen Liu; Guo Chen; Zezhen Liu; Shaoyou Liu; Zhiduan Cai; Pan You; Yuepeng Ke; Li Lai; Yun Huang; Hongchang Gao; Liangcai Zhao; Helene Pelicano; Peng Huang; Wallace L McKeehan; Chin-Lee Wu; Cong Wang; Weide Zhong; Fen Wang
Journal:  Cancer Res       Date:  2018-06-11       Impact factor: 12.701

Review 5.  Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma.

Authors:  Jiao Feng; Jingjing Li; Liwei Wu; Qiang Yu; Jie Ji; Jianye Wu; Weiqi Dai; Chuanyong Guo
Journal:  J Exp Clin Cancer Res       Date:  2020-07-06

Review 6.  Key Role of Obesity in Genitourinary Tumors with Emphasis on Urothelial and Prostate Cancers.

Authors:  Matteo Santoni; Alessia Cimadamore; Francesco Massari; Francesco Piva; Gaetano Aurilio; Angelo Martignetti; Marina Scarpelli; Vincenzo Di Nunno; Lidia Gatto; Nicola Battelli; Liang Cheng; Antonio Lopez-Beltran; Rodolfo Montironi
Journal:  Cancers (Basel)       Date:  2019-08-22       Impact factor: 6.639

7.  Functional Assessment of Four Novel Immune-Related Biomarkers in the Pathogenesis of Clear Cell Renal Cell Carcinoma.

Authors:  Daojun Lv; Xiangkun Wu; Ming Wang; Wenzhe Chen; Shuxin Yang; Yongda Liu; Guohua Zeng; Di Gu
Journal:  Front Cell Dev Biol       Date:  2021-03-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.